Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - amlodipine besilate 6,93 mg - eq. amlodipine 5 mg; valsartan 80 mg - film-coated tablet - 5 mg - 80 mg - amlodipine besilate 6.93 mg; valsartan 80 mg - valsartan and amlodipine

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - amlodipine besilate 6,93 mg - eq. amlodipine 5 mg; valsartan 160 mg - film-coated tablet - 5 mg - 160 mg - amlodipine besilate 6.93 mg; valsartan 160 mg - valsartan and amlodipine

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - amlodipine besilate 13,86 mg - eq. amlodipine 10 mg; valsartan 160 mg - film-coated tablet - 10 mg - 160 mg - amlodipine besilate 13.86 mg; valsartan 160 mg - valsartan and amlodipine

Европейский союз - английский - EMA (European Medicines Agency)

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.imprida is indicated in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

Европейский союз - английский - EMA (European Medicines Agency)

novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. copalia is indicated in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.,

Европейский союз - английский - EMA (European Medicines Agency)

novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.exforge is indicated in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - amlodipine besilate 13,87 mg - eq. amlodipine 10 mg; valsartan 160 mg; hydrochlorothiazide 12,5 mg - film-coated tablet - 10 mg - 160 mg - 12,5 mg - amlodipine besilate 13.87 mg; valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan, amlodipine and hydrochlorothiazide

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - amlodipine besilate 6,94 mg - eq. amlodipine 5 mg; valsartan 160 mg; hydrochlorothiazide 25 mg - film-coated tablet - 5 mg - 160 mg - 25 mg - amlodipine besilate 6.94 mg; valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan, amlodipine and hydrochlorothiazide

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - amlodipine besilate 13,87 mg - eq. amlodipine 10 mg; valsartan 160 mg; hydrochlorothiazide 25 mg - film-coated tablet - 10 mg - 160 mg - 25 mg - amlodipine besilate 13.87 mg; valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan, amlodipine and hydrochlorothiazide